VENDOR COMPARISON

Paradigm Peptide vs Peptide Partners

Independent side-by-side comparison across the 3 peptides both vendors sell. Composite scores, lab quality, and verified pricing.

Paradigm Peptide

Research
B+
Score
7.4
Peptides
6
Tests
54

Top Retatrutide vendor by score (9.0 across 14 tests). Strong on metabolic peptides.

Paradigm Peptide full review →

Peptide Partners

Research
A
Score
8.4
Peptides
7
Tests
71

Peptide Partners ranks A overall on 71 lab tests across 7 peptides, with the Ipamorelin line (avg 9.9 across 7 tests) and Retatrutide line (avg 8.8 across 19 tests) carrying the score. Per-batch COAs are published with HPLC and mass spec; customer satisfaction sits at 4.8/5 acro…

Peptide Partners full review →

Side-by-side breakdown

PEPTIDE PARADIGM PEPTIDE PEPTIDE PARTNERS WINNER
Ipamorelin
9.0 A (6 tests)
9.9 A (7 tests)
Peptide Partners
Tirzepatide
8.4 B+ (14 tests)
8.2 C (6 tests)
Paradigm Peptide
Retatrutide
7.0 B (14 tests)
8.8 B+ (19 tests)
Peptide Partners
TB-500
(not sold)
8.1 A (11 tests)
Peptide Partners only
BPC-157
(not sold)
8.0 A (7 tests)
Peptide Partners only
Tesamorelin
(not sold)
7.8 B+ (11 tests)
Peptide Partners only
CJC-1295
(not sold)
6.7 C (9 tests)
Peptide Partners only

Which to choose

Across the 3 peptides both vendors sell, Paradigm Peptide scores higher on 0, Peptide Partners scores higher on 2, and 1 are within 0.3 points (effectively tied). Peptide Partners additionally sells TB-500, BPC-157, Tesamorelin, CJC-1295; Paradigm Peptide does not.

Choose Peptide Partners for: Ipamorelin, Retatrutide.

Either works for Tirzepatide — composite scores are within 0.3 points.

Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.

Full profiles: Paradigm Peptide review · Peptide Partners review